- Home
- CRWS vs IMMX Comparison
CRWS vs IMMX Comparison
Compare CRWS & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRWS
- IMMX
- Stock Information
- Founded
- CRWS 1957
- IMMX 2014
- Country
- CRWS United States
- IMMX United States
- Employees
- CRWS N/A
- IMMX N/A
- Industry
- CRWS Textiles
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- CRWS Consumer Discretionary
- IMMX Health Care
- Exchange
- CRWS Nasdaq
- IMMX Nasdaq
- Market Cap
- CRWS 48.2M
- IMMX 61.1M
- IPO Year
- CRWS N/A
- IMMX 2021
- Fundamental
- Price
- CRWS $4.55
- IMMX $2.17
- Analyst Decision
- CRWS
- IMMX Strong Buy
- Analyst Count
- CRWS 0
- IMMX 1
- Target Price
- CRWS N/A
- IMMX $7.00
- AVG Volume (30 Days)
- CRWS 17.5K
- IMMX 269.5K
- Earning Date
- CRWS 02-12-2025
- IMMX 11-12-2024
- Dividend Yield
- CRWS 7.03%
- IMMX N/A
- EPS Growth
- CRWS N/A
- IMMX N/A
- EPS
- CRWS 0.32
- IMMX N/A
- Revenue
- CRWS $87,052,000.00
- IMMX N/A
- Revenue This Year
- CRWS N/A
- IMMX N/A
- Revenue Next Year
- CRWS N/A
- IMMX $200.00
- P/E Ratio
- CRWS $14.43
- IMMX N/A
- Revenue Growth
- CRWS 6.33
- IMMX N/A
- 52 Week Low
- CRWS $4.21
- IMMX $1.26
- 52 Week High
- CRWS $5.97
- IMMX $7.50
- Technical
- Relative Strength Index (RSI)
- CRWS 49.16
- IMMX 53.37
- Support Level
- CRWS $4.40
- IMMX $1.88
- Resistance Level
- CRWS $4.57
- IMMX $2.44
- Average True Range (ATR)
- CRWS 0.07
- IMMX 0.32
- MACD
- CRWS -0.00
- IMMX -0.02
- Stochastic Oscillator
- CRWS 51.72
- IMMX 34.94
About CRWS Crown Crafts Inc
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.